ArticlePharmacoEconomics - open2018

Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada.

Graeme Ball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.